Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Aliment Pharmacol Ther ; 45(10): 1329-1338, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28318043

RESUMEN

BACKGROUND: Transplacental transfer of infliximab and adalimumab results in detectable drug levels in the cord blood and infant. AIM: To determine if pregnancy influenced the pharmacokinetics of anti-TNF agents in women with inflammatory bowel disease. METHODS: Twenty-five women from the University of Calgary inflammatory bowel disease(IBD) pregnancy clinic on maintenance infliximab or adalimumab were recruited prospectively with serum bio-banking performed each trimester. Infliximab trough and adalimumab steady-state levels were the outcomes of interest and were analysed using the ANSER infliximab and adalimumab assays. Multivariate linear mixed-effects models were constructed to assess infliximab and adalimumab drug levels during pregnancy adjusting for the clinical covariates of albumin, BMI and CRP. RESULTS: Fifteen women (eight Crohn's disease, seven ulcerative colitis) received infliximab and 10 women with 11 pregnancies were treated with adalimumab. Median age was 29.6 years (IQR: 27.6-31.2 years). Median disease duration was 9.2 years (IQR: 3.16-15.0 years). Median trough infliximab concentrations were 8.50 µg/mL (IQR: 7.23-10.07 µg/mL), 10.31 µg/mL (IQR: 7.66-15.63 µg/mL) and 21.02 µg/mL (IQR: 16.01-26.70 µg/mL) at trimesters 1, 2 and 3 respectively. Significant changes in albumin and BMI (P < 0.05) but not CRP (P > 0.05) were documented throughout pregnancy. After adjusting for albumin, BMI and CRP, infliximab trough levels increased during pregnancy, by 4.2 µg/mL per trimester (P = 0.02), while adalimumab drug levels remained stable (P > 0.05). CONCLUSIONS: Infliximab levels rise during pregnancy, whereas adalimumab levels remain stable after accounting for changes in albumin, BMI and CRP. Therapeutic drug monitoring in the second trimester may be useful in guiding dosing in the third trimester.


Asunto(s)
Adalimumab/metabolismo , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Enfermedades Inflamatorias del Intestino/metabolismo , Infliximab/farmacocinética , Intercambio Materno-Fetal , Adalimumab/farmacología , Adalimumab/uso terapéutico , Adolescente , Adulto , Anticuerpos Monoclonales Humanizados/farmacocinética , Anticuerpos Monoclonales Humanizados/uso terapéutico , Colitis Ulcerosa/tratamiento farmacológico , Colitis Ulcerosa/metabolismo , Enfermedad de Crohn/tratamiento farmacológico , Enfermedad de Crohn/metabolismo , Monitoreo de Drogas , Femenino , Humanos , Infliximab/uso terapéutico , Intercambio Materno-Fetal/efectos de los fármacos , Placenta/efectos de los fármacos , Placenta/metabolismo , Circulación Placentaria , Embarazo , Factor de Necrosis Tumoral alfa/farmacocinética , Factor de Necrosis Tumoral alfa/uso terapéutico , Adulto Joven
2.
Biochim Biophys Acta ; 1862(7): 1337-44, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27085070

RESUMEN

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease is now the leading liver disease in North America. The progression of non-alcoholic fatty liver disease to the inflammatory condition, non-alcoholic steatohepatitis is complex and currently not well understood. Intestinal microbial dysbiosis has been implicated in the development of non-alcoholic fatty liver disease and progression of non-alcoholic steatohepatitis. Volatile organic compounds are byproducts of microbial metabolism in the gut that may enter portal circulation and have hepatotoxic effects contributing to the pathogenesis of non-alcoholic steatohepatitis. To test this hypothesis, we measured volatile organic compounds in cecal luminal contents and portal venous blood in a mouse model of non-alcoholic steatohepatitis. METHODS: Gas chromatography-mass spectrometry analysis was conducted on cecal content and portal vein blood for volatile organic compound detection from mice fed a methionine and choline deficient diet, which induces non-alcoholic steatohepatitis. The colonic microbiome was studied by 16S rRNA gene amplification using the Illumina MiSeq platform. RESULTS: Sixty-eight volatile organic compounds were detected in cecal luminal content, a subset of which was also present in portal venous blood. Importantly, differences in portal venous volatile organic compounds were associated with diet-induced steatohepatitis establishing a biochemical link between gut microbiota-derived volatile organic compounds and increased susceptibility to non-alcoholic steatohepatitis. CONCLUSION: Our model creates a novel tool to further study the role of gut-derived volatile organic compounds in the pathogenesis of non-alcoholic steatohepatitis.


Asunto(s)
Inflamación/microbiología , Hígado/irrigación sanguínea , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/microbiología , Vena Porta/microbiología , Compuestos Orgánicos Volátiles/análisis , Animales , Bacterias/aislamiento & purificación , Células Cultivadas , Modelos Animales de Enfermedad , Inflamación/patología , Mediadores de Inflamación/análisis , Hígado/microbiología , Hígado/patología , Macrófagos/microbiología , Macrófagos/patología , Masculino , Ratones Endogámicos C57BL , Microbiota , Enfermedad del Hígado Graso no Alcohólico/patología , Vena Porta/patología
3.
Cell Death Differ ; 23(8): 1331-46, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-26891693

RESUMEN

Nod-like receptor, pyrin containing 3 (NLRP3) is characterized primarily as a canonical caspase-1 activating inflammasome in macrophages. NLRP3 is also expressed in the epithelium of the kidney and gut; however, its function remains largely undefined. Primary mouse tubular epithelial cells (TEC) lacking Nlrp3 displayed reduced apoptosis downstream of the tumor necrosis factor (TNF) receptor and CD95. TECs were identified as type II apoptotic cells that activated caspase-8, tBid and mitochondrial apoptosis via caspase-9, responses that were reduced in Nlrp3-/- cells. The activation of caspase-8 during extrinsic apoptosis induced by TNFα/cycloheximide (TNFα/CHX) was dependent on adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) and completely independent of caspase-1 or caspase-11. TECs and primary human proximal tubular epithelial cells (HPTC) did not activate a canonical inflammasome, caspase-1, or IL-1ß secretion in response to TNFα/CHX or NLRP3-dependent triggers, such as ATP or nigericin. In cell fractionation studies and by confocal microscopy, NLRP3 colocalized with ASC and caspase-8 in speck-like complexes at the mitochondria during apoptosis. The formation of NLRP3/ASC/caspase-8 specks in response to TNFα/CHX was downstream of TNFR signaling and dependent on potassium efflux. Epithelial ASC specks were present in enteroids undergoing apoptosis and in the injured tubules of wild-type but not Nlrp3-/- or ASC-/- mice following ureteric unilateral obstruction in vivo. These data show that NLRP3 and ASC form a conserved non-canonical platform for caspase-8 activation, independent of the inflammasome that regulates apoptosis within epithelial cells.


Asunto(s)
Apoptosis , Caspasa 8/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Adenosina Trifosfato/farmacología , Animales , Apoptosis/efectos de los fármacos , Caspasa 1/genética , Caspasa 1/metabolismo , Caspasas/genética , Caspasas/metabolismo , Células Cultivadas , Cicloheximida/toxicidad , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , Inflamasomas/metabolismo , Interleucina-1beta/análisis , Interleucina-1beta/metabolismo , Túbulos Renales Proximales/citología , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteína con Dominio Pirina 3 de la Familia NLR/deficiencia , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Nigericina/farmacología , Factor de Necrosis Tumoral alfa/toxicidad
4.
Neurogastroenterol Motil ; 25(6): e441-53, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23600886

RESUMEN

BACKGROUND: Clostridium difficile (Cdf) releases toxins (TcdA and TcdB) that damage the intestinal epithelial barrier. Ecto-5'-nucleotidase (CD73) is expressed on intestinal epithelial cells, and it is hypothesized to protect against toxin-induced epithelial damage through the cleavage of 5'-AMP to adenosine (Ado) and subsequent activation of adenosine receptors (AdoRs). Herein, we sought to assess the potential protective effects of CD73 and AdoR signaling on the injurious effects of Cdf toxins. METHODS: Barrier function was assessed with T84 colonocytes. Transepithelial electrical resistance (TEER), paracellular fluorescein isothiocyanate (FITC)-dextran flux, and tight junction protein (ZO-1) integrity were monitored. Intrarectal installation of Cdf toxin was used to assess epithelial damage in vivo. KEY RESULTS: TcdA/B caused reduced TEER and increased paracellular flux in vitro. Concurrent treatment with 5'-AMP attenuated these responses to Cdf toxin; an effect that was blocked with ZM241385 (AdoRA2 antagonist). APCP, a CD73 inhibitor, also suppressed the protective effects of 5'-AMP on paracellular flux. 5'-AMP reduced toxin-induced disruption of ZO-1, an effect that was abolished by APCP and ZM241385. Inhibition of CD73 with APCP during Cdf toxin exposure led to increased intestinal barrier permeability and epithelial damage in vivo. Intrarectal instillation of 5'-AMP had no effect on toxin-induced intestinal injury. CONCLUSIONS & INFERENCES: Our data suggest that CD73 has a protective role against TcdA/B-induced damage. 5'-AMP treatment attenuated the damaging effects of Cdf toxin in vitro, and inhibitors of CD73 (APCP) and AdoRs (ZM241385) revealed that the cleavage of 5'-AMP to Ado was necessary for the protective effects. Inhibition of CD73 in vivo increases colonic tissue damage and epithelial permeability during Cdf toxin exposure.


Asunto(s)
5'-Nucleotidasa/metabolismo , Proteínas Bacterianas/farmacología , Toxinas Bacterianas/farmacología , Enterotoxinas/farmacología , Mucosa Intestinal/efectos de los fármacos , Receptores Purinérgicos P1/metabolismo , Línea Celular Tumoral , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , Mucosa Intestinal/metabolismo , Permeabilidad , Transducción de Señal , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo
5.
Aliment Pharmacol Ther ; 33(12): 1340-9, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21517923

RESUMEN

BACKGROUND: An association between microscopic colitis and coeliac disease (CD) has been suggested in literature; however, population-based data are limited. AIMS: To estimate the degree of association between these two diseases and to identify possible risk factors for disease concomitance. METHODS: A population-based review of all patients diagnosed with CD and microscopic colitis in a large Canadian centre over a 5-year period. Endoscopy and pathology databases were searched to identify all cases of CD and microscopic colitis diagnosed within the Calgary Health Region between 2004 and 2008. Incidence rates were age-standardised and gender-standardised to 2006 Canadian Census data. standardised incidence ratios (SIR) were used to assess disease concomitance. RESULTS: Over 5 years, 763 patients were diagnosed with CD, and 1106 were diagnosed with microscopic colitis. The standardised incidence of CD ranged from 10.4 to 15.7 per 100,000 population. The standardised incidence of microscopic colitis ranged from 16.9 to 26.2 per 100,000 population. Forty patients were diagnosed with both CD and microscopic colitis, 21 of whom were middle aged (40-60 years) females. Within the CD cohort, microscopic colitis occurred at an annual rate of 11.4 per 1000 cases of CD with an overall SIR of 52.7. CONCLUSIONS: There exists a strong association between microscopic colitis and CD with disease concomitance being approximately 50-times that expected in the general population. The concomitant diagnosis of CD and microscopic colitis largely occurs in middle-aged women. Therefore, middle-aged women with CD and diarrhoea as a presenting or persistent symptom should undergo lower endoscopy with biopsies to rule out microscopic colitis.


Asunto(s)
Enfermedad Celíaca/patología , Colitis Microscópica/patología , Endoscopía Gastrointestinal/métodos , Inmunoglobulina A/metabolismo , Adolescente , Adulto , Anciano , Canadá/epidemiología , Enfermedad Celíaca/epidemiología , Colitis Microscópica/epidemiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Factores de Riesgo , Adulto Joven
6.
Neurogastroenterol Motil ; 23(6): 583-e212, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21414104

RESUMEN

BACKGROUND: Salvinorin A (SA) is the principal active ingredient of Salvia divinorum, with an established inhibitory action on gastrointestinal (GI) transit and colonic ion transport in mice. Under normal conditions, the effects of SA are mediated by kappa opioid (KOR) and cannabinoid (CB1 and CB2) receptors. However, the role of SA in pathophysiological conditions remains unresolved. The aim of this study was to characterize the in vitro and in vivo effects of SA on mouse ileum after endotoxin challenge. METHODS: Changes in GI motility were studied in vitro, using smooth muscle preparations from the mouse ileum. In vivo, the fecal pellet output and small intestinal fluid content were measured. Neurogenic ion transport and intestinal permeability were examined using Ussing chambers. In addition, Western blot analysis of mucosa was performed and plasma nitrite/nitrate levels were determined. KEY RESULTS: Salvinorin A inhibited endotoxin-induced ileal hypercontractility via KOR, CB1, and CB2 receptors. Neurogenic ion transport, which was significantly reduced after endotoxin challenge, was normalized by SA through a nitric oxide synthase (NOS)-dependent mechanism. Western blot analysis and plasma nitrite/nitrate level quantitation confirmed the involvement of NOS in the regulatory action of SA. CONCLUSIONS & INFERENCES: This is the first report showing differential effects of SA on motor and secretory activity in mouse GI during endotoxemia. The outcomes of our study imply possible novel applications of SA and its analogs in the treatment of GI disorders.


Asunto(s)
Diterpenos de Tipo Clerodano/farmacología , Endotoxinas/farmacología , Motilidad Gastrointestinal/efectos de los fármacos , Íleon/efectos de los fármacos , Íleon/fisiología , Transporte Iónico/efectos de los fármacos , Animales , Defecación/efectos de los fármacos , Mucosa Intestinal/metabolismo , Masculino , Ratones , Contracción Muscular/fisiología , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Nitratos/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nitritos/metabolismo
7.
Am J Physiol Gastrointest Liver Physiol ; 299(1): G43-53, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20299601

RESUMEN

Intestinal mucosal integrity is dependent on epithelial function and a regulated immune response to injury. Fucosyltransferase VII (Fuc-TVII) is an essential enzyme required for the expression of the functional ligand for E- and P-selectin. Trefoil factor 3 (TFF3) is involved in both protecting the intestinal epithelium against injury as well as aiding in wound repair following injury. The aim of the present study was to assess the interplay between barrier function and leukocyte recruitment in intestinal inflammation. More specifically, we aimed to examine how targeted disruption of Fuc-TVII either in wild-type or TFF3(-/-) mice would alter their susceptibility to colonic injury. TFF3 and Fuc-TVII double-knockout mice (TFF3/Fuc-TVII(-/-) mice) were generated by mating TFF3(-/-) and Fuc-TVII(-/-) mice. Colitis was induced by administration of dextran sodium sulfate (DSS) (2.5% wt/vol) in the drinking water. Changes in baseline body weight, diarrhea, and fecal blood were assessed daily. Upon euthanasia, extents of colonic inflammation were assessed macroscopically, microscopically, and through quantification of myeloperoxidase (MPO) activity. Colonic lymphocyte subpopulations were assessed at 6 days after administration of DSS by flow cytometry and immunohistochemistry. No baseline intestinal inflammation was found in TFF3/Fuc-TVII(-/-), TFF3(-/-), Fuc-TVII(-/-), or wild-type mice. Loss of Fuc-TVII resulted in a reduction in disease severity whereas TFF3(-/-) mice were markedly more susceptible to DSS-induced colitis. Remarkably, the loss of Fuc-TVII in TFF3(-/-) mice markedly decreased the severity of DSS-induced colitis as evidenced by reduced weight loss, diarrhea, decreased colonic MPO levels and improved survival. Furthermore, the loss of TFF3 resulted in increased severity of spontaneous colitis in IL-2/beta-microglobulin-deficient mice. These studies highlight the importance of the interplay between factors involved in the innate immune response, mucosal barrier function, and genes involved in regulating leukocyte recruitment and other aspects of the immune response.


Asunto(s)
Quimiotaxis de Leucocito , Colitis/enzimología , Fucosiltransferasas/metabolismo , Inmunidad Innata , Mucosa Intestinal/enzimología , Leucocitos/enzimología , Mucinas/metabolismo , Animales , Colitis/inducido químicamente , Colitis/genética , Colitis/inmunología , Colitis/patología , Colitis/prevención & control , Sulfato de Dextran , Diarrea/enzimología , Diarrea/genética , Diarrea/inmunología , Modelos Animales de Enfermedad , Fucosiltransferasas/deficiencia , Fucosiltransferasas/genética , Interleucina-2/deficiencia , Interleucina-2/genética , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Leucocitos/inmunología , Leucocitos/patología , Melena/enzimología , Melena/genética , Melena/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mucinas/deficiencia , Mucinas/genética , Peroxidasa/metabolismo , Índice de Severidad de la Enfermedad , Factores de Tiempo , Factor Trefoil-3 , Pérdida de Peso , Microglobulina beta-2/deficiencia , Microglobulina beta-2/genética
8.
Can J Gastroenterol ; 22(11): 931-6, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19018339

RESUMEN

BACKGROUND: Gastric variceal bleeding is associated with significant morbidity and mortality in patients with portal hypertension. Outside of North America, gastric variceal injection of N-butyl-2-cyanoacrylate has been shown to be safe and effective. The majority of studies on this mode of therapy are in Asian populations in which the etiology of portal hypertension differs from North America. AIM: To assess the safety and efficacy of gastric variceal glue injection in a North American population. METHODS: Consecutive patients that underwent glue injection of gastric varices in the Calgary Health Region from 2001 to 2006 were assessed. RESULTS: Thirty-four patients (19 men, 15 women) underwent a total of 47 separate gluing procedures. Of those presenting with active bleeding at endoscopy, immediate hemostasis was achieved in 93.8% of patients. Rebleeding within 48 h of gluing was observed after four procedures. Gastric varices were eradicated in 84.0% of cases. Complications included superior mesenteric vein thrombosis in one patient. Twenty-eight (82.4%) patients were alive at the end of follow-up. The treatment failure-related mortality rate was 2.1%. CONCLUSIONS: The present study is one of the few to assess the role of gastric variceal gluing in a North American population. Glue injection with cyanoacrylate is safe and effective in the treatment of bleeding gastric varices.


Asunto(s)
Enbucrilato/administración & dosificación , Endoscopía Gastrointestinal/métodos , Várices Esofágicas y Gástricas/terapia , Hemorragia Gastrointestinal/terapia , Hemostasis Endoscópica/métodos , Adulto , Anciano , Alberta/epidemiología , Várices Esofágicas y Gástricas/complicaciones , Várices Esofágicas y Gástricas/epidemiología , Femenino , Estudios de Seguimiento , Hemorragia Gastrointestinal/epidemiología , Hemorragia Gastrointestinal/etiología , Humanos , Incidencia , Inyecciones Intralesiones , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Estómago , Resultado del Tratamiento , Población Urbana
9.
J Cyst Fibros ; 7(1): 1-6, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17766191

RESUMEN

The life expectancy for cystic fibrosis (CF) patients has increased dramatically over the last 30 years. Although the overall cancer risk for CF patients does not appear to be increased there is a marked increased risk of gastrointestinal malignancies especially in the post lung transplant population. CF patients that do develop gastrointestinal malignancies do so at an earlier age and there is often a lag in the diagnosis and management of these individuals. We present a 39 year old male CF patient that underwent a colonoscopy for colon cancer screening and a large, near obstructing, villous adenoma of his ileum was found. The polyp was removed successfully via endoscopy without incident and there was no evidence of malignancy. An upper endoscopy revealed a long segment of Barrett's esophagus with no evidence of dysplasia. We present this case as well as a detailed review of the literature on cancer risk in CF and a discussion of the mechanisms that may be involved. We also present the risk of GI malignancies in non-CF patients as a guide on how to assess and manage the risk of GI malignancies in this ever-changing patient population.


Asunto(s)
Adenoma Velloso/complicaciones , Esófago de Barrett/complicaciones , Fibrosis Quística/complicaciones , Neoplasias del Íleon/complicaciones , Adenoma Velloso/patología , Adulto , Esófago de Barrett/patología , Colonoscopía , Endoscopía Gastrointestinal , Predisposición Genética a la Enfermedad , Humanos , Neoplasias del Íleon/patología , Masculino , Factores de Riesgo
10.
J Pediatr Surg ; 42(11): 1907-12, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18022445

RESUMEN

BACKGROUND/PURPOSE: Gallbladder polyps are relatively common in adults and may increase the risk of gallbladder cancer. The increased use of high-quality abdominal ultrasonography has likely led to the increase detection of these lesions in the pediatric population. The aim of the present study was to address the significance of the ultrasonographic finding of a gallbladder polyp in children. METHODS: This prospective case series of 4 children with ultrasonographically defined gallbladder polyps outlines their presentation and clinical course. A detailed review of the literature and a management approach has been provided. RESULTS: In the 4 cases, polyps were followed for 2, 5, 72, and 84 months with a clinical follow-up of 7 to 11 years. Three underwent cholecystectomy and only 1 of 3 had a polypoid gallbladder lesion. One child, followed for 7 years, had no change in size, shape, or location of the polyp. This case series adds to the small group of children in the literature with polypoid gallbladder lesions and, to our knowledge, none have developed malignant transformation. CONCLUSIONS: Clearly more studies on such children are required to further add to our knowledge on the natural history and the appropriate management of these lesions.


Asunto(s)
Colecistectomía Laparoscópica/métodos , Enfermedades de la Vesícula Biliar/diagnóstico por imagen , Enfermedades de la Vesícula Biliar/cirugía , Pólipos/diagnóstico por imagen , Pólipos/cirugía , Dolor Abdominal/diagnóstico , Dolor Abdominal/etiología , Adolescente , Niño , Preescolar , Femenino , Estudios de Seguimiento , Enfermedades de la Vesícula Biliar/fisiopatología , Humanos , Masculino , Pólipos/fisiopatología , Complicaciones Posoperatorias , Estudios Prospectivos , Medición de Riesgo , Muestreo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Ultrasonografía Doppler
11.
Biochem Soc Trans ; 35(Pt 5): 1375-6, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17956355

RESUMEN

Chronic inflammatory conditions such as ulcerative colitis and Crohn's disease are associated with an increased risk of developing adenocarcinoma. It has been hypothesized that this increased risk may be related to soluble mediators present in the inflammatory environment and that factors involved in exacerbating the inflammatory response could increase the risk of developing colitis-associated cancer. There is a growing body of evidence from both clinical studies and animal models which suggests that colitis occurs due to an aberrant immune response to enteric flora in genetically susceptible individuals. It is well documented that bacterial toxins such as endotoxin have potent pro-inflammatory effects through activation of TLR4 (Toll-like receptor 4) and therefore this molecule could potentially play a prominent role in the initiation/exacerbation of colitis and adenocarcinoma development. Using genetic mutant mice, we have examined the role of TLR4 in a spontaneously developing mouse model of colitis-associated adenocarcinoma: the IL-10(-/-) (interleukin-10-deficient) mouse. Surprisingly, our evidence suggests that the absence of TLR4 promotes colitis-associated adenocarcinoma in IL-10(-/-) mice. TLR4-dependent chemokine induction may play a part in modulating the development of colitis-associated neoplasia through altered leucocyte recruitment.


Asunto(s)
Adenocarcinoma/patología , Colitis/patología , Interleucina-10/fisiología , Receptor Toll-Like 4/fisiología , Adenocarcinoma/genética , Animales , Colitis/genética , Interleucina-10/genética , Ratones
12.
Obes Surg ; 17(6): 843-6, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17879590

RESUMEN

There are reports of gastric carcinoma following bariatric surgery, but it is unclear if these procedures predispose to malignancy. We present a case of a 60-year-old man who, 15 years after vertical banded gastroplasty (VBG), had a massive upper GI bleed. Endoscopy revealed a large tumor of the gastric pouch. Histology confirmed an intestinal type of gastric adenocarcinoma arising in a background of H. pylori-negative gastritis with atrophy, foveolar hyperplasia and intestinal metaplasia. An incidental tubular adenoma at the pylorus was also identified. The pathogenesis of gastric pouch carcinoma is discussed. The present example of neoplastic change in both the pouch and pylorus may indicate that a field effect for dysplasia develops subsequent to VBG.


Asunto(s)
Adenocarcinoma/etiología , Adenoma/etiología , Gastroplastia , Complicaciones Posoperatorias , Neoplasias Gástricas/etiología , Adenocarcinoma/patología , Adenoma/patología , Humanos , Masculino , Persona de Mediana Edad , Obesidad Mórbida/cirugía , Neoplasias Gástricas/patología
13.
Cancer Gene Ther ; 14(10): 867-72, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17627293

RESUMEN

Reovirus type 3 Dearing has demonstrated oncolytic efficacy in vitro and in vivo against a variety of cancer cell lines, tumor xenografts and syngeneic cancer models. In this study, we investigated the effectiveness of reovirus against aberrant crypt foci (ACF) and colon cancer induced by the carcinogen azoxymethane (AOM) in an immunocompetent rat model. Sprague-Dawley rats received 15 mg/kg AOM intraperitoneally once per week for 4 weeks and reovirus was administered rectally once a week for 5 weeks starting 20 weeks after the last dose of AOM. Two weeks after completion of reovirus therapy, animals were examined for tumor burden in the colon and other tissues. Reovirus-treated animals showed a decrease in total ACF numbers (P=0.014), in large ACFs (P=0.0069) and in tumor number (P=0.03) compared to vehicle-treated animals. Fewer obstructing tumors in the colon (P=0.07) and duodenum (P=0.03) and reduced hepatic metastases were also noted. In addition, a tumor cell line derived from hepatic metastases was found to be susceptible to reovirus in vitro. Our results show that repeated rectal reovirus administration had some efficacy in the treatment and prevention of AOM-induced ACFs, colon cancers and metastases.


Asunto(s)
Adenocarcinoma/prevención & control , Azoximetano/toxicidad , Carcinógenos/toxicidad , Neoplasias del Colon/prevención & control , Orthoreovirus/fisiología , Lesiones Precancerosas/prevención & control , Adenocarcinoma/inducido químicamente , Adenocarcinoma/inmunología , Animales , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/inmunología , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/inmunología , Femenino , Linfocitos/inmunología , Masculino , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/inmunología , Ratas , Ratas Sprague-Dawley
14.
World J Gastroenterol ; 12(41): 6665-73, 2006 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-17075981

RESUMEN

AIM: To review all studies in the literature that have assessed Hematopoietic cell transplantation (HCT) and Crohn's disease (CD) with the ultimate aims of determining if this is a viable treatment option for those with CD. A secondary aim was to review the above literature and determine if the studies shed further light on the mechanisms involved in the pathogenesis of CD. METHODS: An extensive Medline search was performed on all articles from 1970 to 2005 using the keywords; bone marrow transplant, stem cell, hematopoietic cell, Crohn's disease and inflammatory bowel disease. RESULTS: We identified one case in which a patient developed CD following an allogeneic HCT from a sibling suffering with CD. Evidence for transfer of the genetic predisposition to develop CD was also identified with report of a patient that developed severe CD following an allogeneic HCT. Following HCT it was found that the donor (that had no signs or symptoms of CD) and the recipient had several haplotype mismatches in HLA class III genes in the IBD3 locus including a polymorphism of NOD2/CARD15 that has been associated with CD. Thirty three published cases of patients with CD who underwent either autologous or allogeneic HCT were identified. At the time of publication 29 of these 33 patients were considered to be in remission. The median follow-up time was seven years, and twenty months for allogeneic and autologous HCT respectively. For patients who underwent HCT primarily for treatment of their CD there have been no mortalities related to transplant complications. CONCLUSION: Overall these preliminary data suggest that both allogeneic and autologous HCT may be effective in inducing remission in refractory CD. This supports the hypothesis that the hematolymphatic cells play a key role in CD and that resetting of the immune system may be a critical approach in the management or cure of CD.


Asunto(s)
Enfermedad de Crohn/fisiopatología , Enfermedad de Crohn/terapia , Trasplante de Células Madre Hematopoyéticas/métodos , Enfermedades Autoinmunes/terapia , Células de la Médula Ósea/patología , Enfermedad de Crohn/inmunología , Femenino , Humanos , Terapia de Inmunosupresión/métodos , Masculino , Trasplante Autólogo/métodos , Trasplante Homólogo/métodos
15.
World J Gastroenterol ; 12(26): 4117-29, 2006 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-16830359

RESUMEN

Short bowel syndrome (SBS) refers to the malabsorption of nutrients, water, and essential vitamins as a result of disease or surgical removal of parts of the small intestine. The most common reasons for removing part of the small intestine are due to surgical intervention for the treatment of either Crohn's disease or necrotizing enterocolitis. Intestinal adaptation following resection may take weeks to months to be achieved, thus nutritional support requires a variety of therapeutic measures, which include parenteral nutrition. Improper nutrition management can leave the SBS patient malnourished and/or dehydrated, which can be life threatening. The development of therapeutic strategies that reduce both the complications and medical costs associated with SBS/long-term parenteral nutrition while enhancing the intestinal adaptive response would be valuable. Currently, therapeutic options available for the treatment of SBS are limited. There are many potential stimulators of intestinal adaptation including peptide hormones, growth factors, and neuronally-derived components. Glucagon-like peptide-2 (GLP-2) is one potential treatment for gastrointestinal disorders associated with insufficient mucosal function. A significant body of evidence demonstrates that GLP-2 is a trophic hormone that plays an important role in controlling intestinal adaptation. Recent data from clinical trials demonstrate that GLP-2 is safe, well-tolerated, and promotes intestinal growth in SBS patients. However, the mechanism of action and the localization of the glucagon-like peptide-2 receptor (GLP-2R) remains an enigma. This review summarizes the role of a number of mucosal-derived factors that might be involved with intestinal adaptation processes; however, this discussion primarily examines the physiology, mechanism of action, and utility of GLP-2 in the regulation of intestinal mucosal growth.


Asunto(s)
Hormonas Gastrointestinales/fisiología , Péptidos Similares al Glucagón/fisiología , Intestino Delgado/fisiopatología , Síndrome del Intestino Corto/fisiopatología , Animales , Sistema Nervioso Central/fisiología , Sistema Nervioso Entérico/fisiología , Péptido 2 Similar al Glucagón , Receptor del Péptido 2 Similar al Glucagón , Péptidos Similares al Glucagón/farmacología , Péptidos Similares al Glucagón/uso terapéutico , Humanos , Absorción Intestinal/efectos de los fármacos , Absorción Intestinal/fisiología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/crecimiento & desarrollo , Mucosa Intestinal/patología , Intestino Delgado/inervación , Intestino Delgado/cirugía , Síndromes de Malabsorción/complicaciones , Complicaciones Posoperatorias , Receptores de Glucagón/efectos de los fármacos , Receptores de Glucagón/fisiología , Síndrome del Intestino Corto/tratamiento farmacológico , Síndrome del Intestino Corto/etiología
16.
Can J Gastroenterol ; 19(6): 367-71, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15997270

RESUMEN

Disseminated herpes simplex virus (HSV) infection usually manifests in the immunocompromised. However, anecdotal examples of visceral HSV disease and viremia have complicated type I diabetes. A case of a 53-year-old type I diabetic patient with bowel obstruction one week subsequent to bronchitis is reported. At laparotomy, a perforated segment of ileum was associated with an adhesive peritoneal band. HSV cytopathic atypia and HSV immunohistochemical staining were confined to fibrocytes and mesothelial cells without involvement of the epithelium. Dissemination of symptomatic HSV pneumonia was verified by histology, immunohistochemistry, in situ hybridization, polymerase chain reaction and direct fluorescence antibody. Intravenous acyclovir resolved symptoms. This is a novel documentation of HSV complicating ileal adhesive band disease. Furthermore, this case indicates that the HSV cytopathic effect is not unique to the epithelium. Disseminated infection can manifest in myofibrocytes and mesothelium, distinguishing it from standard epithelial atypia of localized HSV infection.


Asunto(s)
Herpes Simple/virología , Herpesvirus Humano 2/aislamiento & purificación , Enfermedades del Íleon/virología , Mucosa Intestinal/virología , Aciclovir/uso terapéutico , Anticuerpos Antivirales/sangre , Antivirales/uso terapéutico , ADN Viral/análisis , Diagnóstico Diferencial , Femenino , Herpes Simple/diagnóstico , Herpes Simple/tratamiento farmacológico , Humanos , Enfermedades del Íleon/diagnóstico , Enfermedades del Íleon/tratamiento farmacológico , Hibridación in Situ , Mucosa Intestinal/patología , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa
17.
Can J Gastroenterol ; 18(11): 681-5, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15565209

RESUMEN

Intestinal lymphangiectasia, which can be classified as primary or secondary, is an unusual cause of protein-losing enteropathy. The main clinical features include edema, fat malabsorption, lymphopenia and hypoalbuminemia. Clinical management generally includes a low-fat diet and supplementation with medium chain triglycerides. A small number of recent reports advocate the use of octreotide in intestinal lymphangiectasia. It is unclear why octreotide was used in these studies; although octreotide can alter splanchnic blood flow and intestinal motility, its actions on lymphatic function has never been investigated. A case of a patient with intestinal lymphangiectasia who required a shunt procedure after failing medium chain triglycerides and octreotide therapy is presented. During the management of this case, all existing literature on intestinal lymphangiectasia and all the known actions of octreotide were reviewed. Because some of the case reports suggested that octreotide may improve the clinical course of intestinal lymphangiectasia by altering lymphatic function, a series of experiments were undertaken to assess this. In an established guinea pig model, the role of octreotide in lymphatic function was examined. In this model system, the mesenteric lymphatic vessels responded to 5-hydroxytryptamine with a decrease in constriction frequency, while histamine administration markedly increased lymphatic constriction frequency. Octreotide failed to produce any change in lymphatic function when a wide range of concentrations were applied to the mesenteric lymphatic vessel preparation. In conclusion, in this case, octreotide failed to induce a clinical response and laboratory studies showed that octreotide did not alter lymphatic function. Thus, the mechanisms by which octreotide induced clinical responses in the cases reported elsewhere in the literature remain unclear, but the present study suggests that it does not appear to act via increasing lymphatic pumping.


Asunto(s)
Fármacos Gastrointestinales/farmacología , Fármacos Gastrointestinales/uso terapéutico , Linfangiectasia Intestinal/tratamiento farmacológico , Vasos Linfáticos/efectos de los fármacos , Octreótido/farmacología , Octreótido/uso terapéutico , Adulto , Animales , Modelos Animales de Enfermedad , Femenino , Cobayas , Humanos , Técnicas de Cultivo de Tejidos , Insuficiencia del Tratamiento
18.
Can J Gastroenterol ; 18(10): 625-9, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15497003

RESUMEN

Methemoglobinemia is a rare complication that can occur with the use of benzocaine-containing compounds. Two cases of methemoglobinemia are reported, and the pathophysiology and treatment of methemoglobinemia are reviewed. Both patients received topical 20% benzocaine spray before endoscopy. Immediately following the procedure, there was a reduction in O2 saturation assessed by pulse oximetry that was refractory to O2 therapy. Dramatic peripheral and central cyanosis developed. O2 saturation measured by pulse oximetry ranged from 83% to 87% on O2 by nasal prongs and 100% O2 by a nonrebreathing mask. Both patients were mildly confused and one patient complained of a significant headache. The diagnosis of methemoglobinemia was considered and arterial blood gas sampling was performed. In both patients, the arterial blood had a chocolate brown colour. A methemoglobin level of 48% and 18% was noted in patient 1 and patient 2, respectively. Both patients were treated with methylene blue, resulting in a significant improvement with gradual normalization of their O2 saturation within 10 min to 30 min. The use of benzocaine spray may not markedly alter the patient's perception of endoscopy and thus, the routine use of these agents should be questioned. If such agents are used, the physician must be aware of this association to prevent a delay in the diagnosis and management of this rare, but potentially lethal, condition.


Asunto(s)
Benzocaína/efectos adversos , Endoscopía Gastrointestinal/efectos adversos , Metahemoglobinemia/inducido químicamente , Adulto , Anestesia Local/efectos adversos , Anestesia Local/métodos , Benzocaína/uso terapéutico , Quimioterapia Combinada , Endoscopía Gastrointestinal/métodos , Femenino , Estudios de Seguimiento , Humanos , Metahemoglobinemia/tratamiento farmacológico , Metahemoglobinemia/fisiopatología , Persona de Mediana Edad , Medición de Riesgo , Índice de Severidad de la Enfermedad
19.
Cell Tissue Res ; 318(2): 313-23, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15338270

RESUMEN

Colitis is associated with alterations in electrolyte and water transport. These changes give rise to some of the symptoms experienced by patients with colitis. Alterations in fluid flux may also contribute to increased susceptibility to mucosal injury. Recently, endogenous water channel proteins (aquaporins; AQPs), have been identified in colonic tissue. The expression of AQP4, AQP7 and AQP8 was examined, via reverse transcription/polymerase chain reaction, Western blotting and immunohistochemistry, in a murine model of colitis and in patients with inflammatory bowel disease or infectious colitis. Colitis was induced in C57BL/6 mice by the addition of 2.5% dextran sodium sulphate (DSS) to their drinking water. AQP expression in these mice was assessed following 12 h to 7 days of DSS exposure and during the recovery phase from 1 to 15 days following cessation of DSS exposure. Colonic water transport was measured after 1 and 3 days of DSS and following 7 days of recovery. The expression of AQP4 and AQP8 mRNA was significantly decreased after 12-24 h of DSS exposure and remained depressed throughout the treatment period. Expression of AQP7 was more variable. Protein expression followed a similar pattern to that observed for AQP mRNA. Significant alteration in colonic fluid secretion was correlated with reduced expression of AQP isoforms. Significantly, patients with active ulcerative colonic, Crohn's colitis or infectious colitis had similar dramatic reductions in AQP expression that appeared to be correlated with disease activity. Thus, colonic injury in both mouse and man is associated with a downregulation in AQP expression.


Asunto(s)
Acuaporinas/metabolismo , Colitis Ulcerosa/metabolismo , Enfermedad de Crohn/metabolismo , Regulación hacia Abajo , Animales , Acuaporinas/genética , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/patología , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Enfermedad de Crohn/patología , Sulfato de Dextran , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
20.
Can J Gastroenterol ; 18(5): 329-32, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15152284

RESUMEN

A 64-year-old man with treated hypothyroidism had 10 months of diarrhea, abdominal pain, anorexia and recent involuntary 13.6 kg weight loss. He presented to hospital with an acute abdomen that had a radiological correlate of free air under the diaphragm. He was diagnosed with a perforated mid-jejunum due to an ulcerated enteropathy-type T cell lymphoma (ETL), complicating collagenous sprue and cryptic celiac disease. Polymerase chain reaction verified monoclonal gamma- and beta-T cell receptor gene rearrangements in the neoplasm. He had a complete resolution of symptoms when treated with a gluten-free diet in the postoperative period. This is apparently the first report describing collagenous sprue and ETL as synchronous lesions. Because atypical CD8+ lymphocytes are in both the collagenous sprue epithelium and ETL, the implication is that collagenous sprue is a noninvasive component of the ETL.


Asunto(s)
Enfermedad Celíaca/diagnóstico , Neoplasias del Yeyuno/diagnóstico , Linfoma de Células T/diagnóstico , Complejo CD3/análisis , Antígenos CD8/análisis , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/patología , Reordenamiento Génico de la Cadena gamma de los Receptores de Antígenos de los Linfocitos T , Humanos , Inmunohistoquímica , Mucosa Intestinal/patología , Neoplasias del Yeyuno/complicaciones , Neoplasias del Yeyuno/genética , Neoplasias del Yeyuno/patología , Linfoma de Células T/complicaciones , Linfoma de Células T/genética , Linfoma de Células T/patología , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA